SciClone Pharmaceuticals Inc (NASDAQ:SCLN)
| 4.83 Data as of May 17 |  -0.14 / -2.82%Today’s Change | 3.68 Today|||52-Week Range 7.58 | +12.07% Year-to-Date |
Latest SCLN News | Press Releases
No recent news for SciClone Pharmaceuticals Inc.
Today’s Trading
| Previous close | 4.97 |
| Today’s open | 4.98 |
| Day’s range | 4.77 - 4.98 |
| Volume | 224,726 |
| Average volume (3 months) | 261,979 |
| Market cap | $260.9M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/17/2013
Growth & Valuation
| Earnings growth (last year) | -68.00% |
| Earnings growth (this year) | +275.00% |
| Earnings growth (next 5 years) | +14.70% |
| Revenue growth (last year) | +16.93% |
| P/E ratio | 30.2 |
| Price/Sales | 1.56 |
| Price/Book | 1.84 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RGLSRegulus Therapeutics... | -0.14 | -1.93% |
| ACRXAcelRx Pharmaceutica... | -0.51 | -7.09% |
| ANACAnacor Pharmaceutica... | -0.01 | -0.16% |
| CNDOCoronado Biosciences... | -0.17 | -1.69% |
Data as of 4:00pm ET, 05/17/2013
Financials
| Next reporting date | July 30, 2013 |
| EPS forecast (this quarter) | $0.15 |
| Annual revenue (last year) | $156.3M |
| Annual profit (last year) | $9.6M |
| Net profit margin | 6.16% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Friedhelm Blobel, PhD |
CFO, Senior Vice President & Head-Media Relations Gary S. Titus, CPA |
Corporate headquarters Foster City, California |
Forecasts
